Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Canada flag Canada · Delayed Price · Currency is CAD
0.1650
-0.0050 (-2.94%)
Aug 12, 2025, 3:22 PM EDT
-2.94%
Market Cap28.60M
Revenue (ttm)n/a
Net Income (ttm)-2.18M
Shares Out168.26M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume317,621
Average Volume228,208
Open0.1700
Previous Close0.1700
Day's Range0.1650 - 0.1700
52-Week Range0.0400 - 0.3600
Beta0.87
RSI37.79
Earnings DateJul 28, 2025

About Elevation Oncology

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The compan... [Read more]

Sector Healthcare
CEO Brent Willis
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol VM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.